Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Biomedicines|September 23, 2022
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic OptionsTeresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules|November 27, 2024
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney DiseaseAlfredo Caturano, Raffaele Galiero, Maria Rocco, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World StudyErica Vetrano, Raffaele Galiero, Vittorio Simeon, et al.
Cardiovascular Diabetology|March 6, 2019
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE StudyFerdinando Carlo Sasso, Pia Clara Pafundi, Raffaele Marfella, et al.
Diabetes, Obesity & Metabolism|February 1, 2024
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot studyErnesto Maddaloni, Anda M Naciu, Carmen Mignogna, et al.
World Journal of Diabetes|November 24, 2025
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: <i>Post-hoc</i> analysis of the nephropathy in diabetes type 2 trialAlfredo Caturano, Vittorio Simeon, Raffaele Galiero, et al.
Acta Diabetologica|November 11, 2024
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT studyAlfredo Caturano, Anna di Martino, Gaetana Albanese, et al.
European Journal of Clinical Pharmacology|May 22, 2023
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experienceEmilio Attena, Alfredo Caturano, Anna Annunziata, et al.
Diabetes Research and Clinical Practice|March 25, 2019
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND studyFerdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso, et al.
Diabetes Research and Clinical Practice|April 26, 2023
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR studyGiuseppe Palmiero, Arturo Cesaro, Raffaele Galiero, et al.
Pageof 7